Richard Doll Seminar: The International 100K+ Cohorts Consortium: Integrating large-scale cohorts to address global scientific challenges

Dr. Ginsburg is the founding director for the Center for Applied Genomics & Precision Medicine at the Duke University Medical Center and for MEDx, a partnership between the Schools of Medicine and Engineering to spark and translate innovation. His research addresses the challenges for translating genomic and digital health information into medical practice and the integration of precision medicine into healthcare. In 2017 he received Duke’s Translational Research Mentorship Award and is a finalist in the NIH/BARDA Antimicrobial Resistance Prize.

He was a member of the Advisory Council to the Director of NIH and is co-chair of the National Academies Roundtable on Genomic and Precision Health and is founder and president of the Global Genomic Medicine Collaborative, a not for profit organization aimed creating international partnerships to advance the implementation of precision medicine. He has recently served as a member of the Board of External Experts for the NHLBI, the advisory council for the National Center for Accelerating Translational Science, chair of the review for Genome Canada’s Large Scale Applied Research Competition in Genomics and Precision Medicine, and the World Economic Forum’s Global Agenda Council on the Future of the Health Sector.  He is a founder of Predigen, Inc and MeTree&You, Inc.  He was previously Vice President of Molecular Medicine at Millennium Pharmaceuticals, Inc and a faculty member at Harvard Medical School.

He is the founder and co-chair of the Global Genomic Medicine Collaborative, a not-for-profit (501c(3)) dedicated to implementing genomic medicine with a focus on low resource settings around the globe.  The G2MC operates the International 100K+ Cohorts Consortium of which he is one of the co-chairs along with Teri Manolio (NHGRI) and Peter Goodhand (GA4GH).